市场调查报告书
商品编码
1451733
2024-2032 年按产品、疾病、给药途径、配销通路和地区分類的猪隻保健品市场报告Swine Healthcare Market Report by Product, Disease, Route of Administration, Distribution Channel, and Region 2024-2032 |
2023年,全球猪隻保健市场规模达到30亿美元。展望未来, IMARC Group预计到2032年市场规模将达到53亿美元,2024-2032年复合年增长率(CAGR)为6.48%。对生猪产品的日益依赖、商业生猪养殖和出口活动的大幅增加以及对猪肉传播疾病的认识不断增强,是推动市场发展的一些关键因素。
猪保健是指一系列旨在减轻猪疾病期间不适的产品、治疗程序和诊断试剂盒。它的重点是治疗不孕症和先天性异常等与猪相关的常见疾病,以及开发预防此类疾病的疗法。协调的全球疾病监测、最大限度地减少未来威胁影响的有针对性的研究投资以及资料分析是猪隻医疗保健管理的一部分。除此之外,它还包括预防病毒和细菌,同时透过适当的定时疫苗接种和负责任的抗生素使用来增强牛群疾病免疫力。除了为生猪提供健康服务外,生猪医疗保健系统还透过猪舍设计、猪隻运输、疫苗接种方案、猪群健康监测、疾病监测和适合具体情况的诊断测试,促进最大限度地降低疾病风险。
群众对生猪产品的依赖程度不断增加是推动市场成长的关键因素之一。这可以归因于全球商业养猪和出口活动的大幅成长。同时,包括猪流感、沙门氏菌、猪肺炎支原体和猪瘟(CSF)在内的多种疾病的盛行率不断上升,正在推动市场的发展。此外,人们对猪肉传播疾病的认识不断增强,导致猪隻保健品的使用量增加。此外,政府机构为维护猪隻的健康所采取的有利措施也推动了市场的成长。不断增长的猪肉消费群体推动了对健康生猪牲畜的需求,这进一步为市场提供了动力。除此之外,广泛的研发(R&D)活动,尤其是开发预防猪流感和猪瘟的疫苗以及减少猪病对人类的影响,也为市场做出了贡献。此外,兽医医院越来越多地采用诊断影像,导致对配件和诊断设备的需求不断增加,这也为市场做出了贡献。创造积极市场前景的其他一些因素包括疫苗、抗生素和手术治疗的采用率不断提高,以提高牲畜产量,食源性疾病发病率显着上升,全球化的迅速发展,对有机猪肉的需求不断增加,以及相当大的食品和饮料 (F&B) 行业的成长。
The global swine healthcare market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.48% during 2024-2032. The increasing dependency on swine products, a considerable rise in commercial swine farming and export activities, and the growing awareness regarding pork-transmitted diseases represent some of the key factors driving the market.
Swine healthcare refers to a broad category of products, treatment procedures, and diagnostic kits that aim to alleviate discomfort during swine diseases. It focuses on treatments for common pig-related disorders like infertility and congenital anomalies as well as the development of therapeutics to prevent such diseases. Coordinated global disease monitoring, targeted research investments that minimize future threat effects, and data analysis are part of swine healthcare management. Along with this, it involves the prevention of viruses and bacteria while enhancing herd disease immunity with appropriately timed vaccinations and responsible antibiotic use. In addition to providing health services to pigs, the swine healthcare system promotes minimizing disease risks through barn design, pig movement, vaccination protocols, herd health monitoring, disease surveillance, and diagnostic tests that are appropriate for the situation.
The increasing dependency on swine products among the masses is one of the key factors driving the growth of the market. This can be attributed to a considerable rise in commercial swine farming and export activities across the globe. In line with this, the rising prevalence of numerous diseases, including swine flu, salmonella, mycoplasma hyopneumoniae, and classical swine fever (CSF), is fueling the market. Moreover, the augmenting awareness regarding pork-transmitted diseases is resulting in a higher uptake of swine healthcare products. Also, favorable initiatives taken by government bodies toward swine health maintenance are fueling the market growth. The continuously growing pork-eating population is propelling the demand for healthy swine livestock, which is further providing an impetus to the market. Besides this, extensive research and development (R&D) activities with an enhanced focus on the development of vaccines to prevent swine flu and swine fever and reduce the effects of swine diseases on humans are contributing to the market. Additionally, the augmenting incorporation of diagnostic imaging in veterinary hospitals leading to an escalating demand for accessories and diagnostic equipment is contributing to the market. Some of the other factors creating a positive market outlook include the growing adoption rates of vaccines, antibiotics, and surgical treatments for increasing livestock production, a significant rise in the rates of foodborne diseases, rapid globalization, the accelerating demand for organic pork, and considerable growth in the food and beverage (F&B) industry.
IMARC Group provides an analysis of the key trends in each segment of the global swine healthcare market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, disease, route of administration and distribution channel.
Diagnostic Tests
Enzyme Linked Immuno-Sorbent Assay (ELISA)
Rapid Immuno Migration (RIM)
Agar Gel Immuno-Diffusion (AGID)
Polymerase Chain Reaction (PCR)
Diagnostic Imaging
Others
Therapeutics
Vaccines
Parasiticides
Anti-infectives
Feed Additives
Others
The report has also provided a detailed breakup and analysis of the swine healthcare market based on the product. This includes diagnostic tests (Enzyme Linked Immuno-Sorbent Assay (ELISA), Rapid Immuno Migration (RIM), Agar Gel Immuno-Diffusion (AGID), Polymerase Chain Reaction (PCR), Diagnostic Imaging, and others) and therapeutics (vaccines, parasiticides, anti-infectives, feed additives, and others). According to the report, therapeutics represented the largest segment.
Exudative Dermatitis
Coccidiosis
Respiratory Diseases
Swine Dysentery
Porcine Parvovirus
Others
A detailed breakup and analysis of the swine healthcare market based on the disease has also been provided in the report. This includes exudative dermatitis, coccidiosis, respiratory diseases, swine dysentery, porcine parvovirus, and others. According to the report, respiratory diseases accounted for the largest market share.
Injectable
Oral
A detailed breakup and analysis of the swine healthcare market based on the route of administration has also been provided in the report. This includes injectable and oral.
Veterinary Hospitals
Retail Pharmacy
Online Pharmacy
A detailed breakup and analysis of the swine healthcare market based on the distribution channel has also been provided in the report. This includes veterinary hospitals, retail pharmacy and online pharmacy.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for swine healthcare. Some of the factors driving the North America swine healthcare market included the growing consumption of pork, improving animal healthcare infrastructure, the growing consciousness regarding pork-transmitted diseases, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global swine healthcare market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva Animal Health Inc., Elanco, IDEXX Laboratories Inc., Innovative Diagnostic, Merck & Co. Inc., Phibro Animal Health Corporation, Vetoquinol, Virbac Corporation, Zoetis Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report